The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A review of dose-responses of probiotics in human studies
Open accessAbstract
The probiotic definition requires the administration of an ‘adequate amount’ in order to obtain a health benefit. What that amount should be is not indicated. Here, an overview is given of studies that investigated the dose-response relation of probiotics in human interventions. Studies were divided in; meta-analyses, meta-analyses on specific probiotic strains, and studies testing two or more doses of a probiotic (combination) in the same study. Meta-analyses on the effect of probiotics on antibiotic associated diarrhoea (AAD) suggest a dose-response effect; for Clostridium difficile-associated diarrhoea on the other hand no dose-response was observed. For other end-points; such as necrotising enterocolitis, prevention of atopic dermatitis and slow intestinal transit, no dose-response relation was identified in meta-analyses. For prophylaxis in colorectal cancer and relief of irritable bowel syndrome, no dose-response relation was determined. However, for blood pressure, a meta-analysis observed that higher doses (greater than 10 11 cfu) were more effective than lower doses. Meta-analyses of specific strains suggest a break-point for effectiveness of Lactobacillus rhamnosus GG in the treatment of acute gastroenteritis in children; no dose-response was observed for two other probiotics assessed. Studies comparing two or more doses indicate that faecal recovery and risk reduction of AAD follow a positive dose-response relationship. Other end-points such as immune markers, general health, and bowel function did not exhibit clear dose-response relations. For AAD, the findings are very compelling; both meta-analyses and dedicated dose-response studies observe a positive correlation between dose and AAD risk. These findings do not allow for extrapolation, but suggest that studying higher doses for this end-point would be worthwhile. The lack of a clear dose-response for other end-points, does not mean it does not exist; present data does just not allow drawing any conclusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
Khalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases
Ritchie, M. L., & Romanuk, T. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034938 · Cited by 474
Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., & Miller, L. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.11 · Cited by 318
Gianotti, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i2.167 · Cited by 209
Waller, P. A., Gopal, P. K., Leyer, G. J., Ouwehand, A. C., Reifer, C., Stewart, M. E., & Miller, L. E. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.584895 · Cited by 195
Self-citationChamberlain, R., & Lau, C. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s98280 · Cited by 177
Miller, L. E. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i29.4718 · Cited by 114
McFarland, L. (2015) · Antibiotics · doi:10.3390/antibiotics4020160 · Cited by 109
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
Lyra, A., Hillilä, M., Huttunen, T., Männikkö, S., Taalikka, M., Tennilä, J., Tarpila, A., Lahtinen, S., Ouwehand, A. C., & Veijola, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10631 · Cited by 106
Self-citationProbiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
Ouwehand, A. C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., & Miller, L. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.053 · Cited by 98 · cited 1×
“In particular the three studies dealing with AAD (Gao et al. , 2010; Imase et al. , 2008; Ouwehand et al. , 2014) provide the most convincing data on dose dependence for the use of probiotics in human intervention trials.”
Self-citationImase, K., Takahashi, M., Tanaka, A., Tokunaga, K., Sugano, H., Tanaka, M., Ishida, H., Kamiya, S., & Takahashi, S. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00026.x · Cited by 81 · cited 1×
“In particular the three studies dealing with AAD (Gao et al. , 2010; Imase et al. , 2008; Ouwehand et al. , 2014) provide the most convincing data on dose dependence for the use of probiotics in human intervention trials.”
Research works printed but not linked: 42
- 10.1186/s13052-015-0199-2 · DOI
- Journal of Nutrition Health and Aging, 11, 26
- Cochrane Database of Systematic Reviews, 4, CD005496
- Cochrane Database of Systematic Reviews, CD005496
- 10.3945/ajcn.114.092551 · DOI
- 10.1177/0148607115588113 · DOI
- Nutrición Hospitalaria, 27, 504
- 10.1111/j.1574-695X.2006.00109.x · DOI
- 10.1016/S0140-6736(07)60748-X · DOI · Paper page
- 10.1093/tropej/fmp001 · DOI
- Cochrane Database of Systematic Reviews, 5, CD006095
- 10.3920/BM2014.0031 · DOI
- 10.1016/j.clinre.2012.10.007 · DOI
- Sexually Transmitted Infections, 36, 564
- 10.1186/1471-230X-9-15 · DOI · Paper page
- Cochrane Database of Systematic Reviews, CD004827
- 10.1503/cmaj.051603 · DOI · Paper page
- Fortschritte der Medizin, 111, 152
- Travel Medicine International, 7, 9
- 10.1038/sj.ejcn.1602450 · DOI · Paper page
- 10.1016/j.jpedsurg.2015.05.008 · DOI
- International Journal of General Medicine, 9, 27
- 10.3748/wjg.v20.i26.8709 · DOI
- 10.1089/bfm.2015.0070 · DOI
- Nutrición Hospitalaria, 26, 228
- 10.1186/1472-6882-10-13 · DOI · Paper page
- MMW – Fortschritte der Medizin, 156, 61
- 10.3748/wjg.v22.i21.5122 · DOI · Paper page
- 10.1007/s15010-013-0496-x · DOI
- 10.1159/000441274 · DOI
- 10.1097/EDE.0b013e31824d5da2 · DOI · Paper page
- 10.1002/ebch.1977 · DOI
- 10.1016/j.ijfoodmicro.2010.12.026 · DOI
- 10.1016/0168-1605(94)00091-J · DOI
- 10.1017/S0007114512003753 · DOI
- 10.1111/apt.13344 · DOI · Paper page
- 10.1111/apt.12403 · DOI · Paper page
- 10.1097/INF.0000000000000948 · DOI
- 10.1542/peds.109.4.678 · DOI · Paper page
- 10.1111/j.1572-0241.2006.00734.x · DOI · Paper page
- 10.1097/MD.0000000000002562 · DOI
- 10.1186/s12876-016-0470-z · DOI · Paper page
Cited by
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Fermented Foods as a Dietary Source of Live Organisms
Rezac, S., Kok, C. R., Heermann, M., & Hutkins, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01785 · Cited by 540
Criteria to Qualify Microorganisms as “Probiotic” in Foods and Dietary Supplements
Binda, S., Hill, C., Johansen, E., Obis, D., Pot, B., Sanders, M. E., Tremblay, A., & Ouwehand, A. C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01662 · Cited by 519
Self-citationProbiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
Sniffen, J. C., McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209205 · Cited by 265
Metadata
- Authors
- Ouwehand, A. C.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-04-26
- Volume
- 8
- Issue
- 2
- Pages
- 143-151
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2562334998
- Cited by
- 233
- References
- 13
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.